Cite
HARVARD Citation
Oze, T. et al. (2015). The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1. Journal of viral hepatitis. 22 (3), pp. 254-262. [Online].